{
  "retracted": false,
  "timestamp": 1567987200000,
  "updates": [
    {
      "timestamp": 1585338918613,
      "identifier": {
        "doi": "10.1007/s12325-019-01082-6"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s12325-019-01052-y"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis"
}
